Of note, a number of cancers have documented upregulation of rictor including lung cancer, sarcoma, neuroendocrine prostate, esophagus and stomach cancers, rendering this protein as a potential therapeutic target [25]. This evidence concerns the gene RICTOR and lung carcinoma.